|
1
|
Annane D, Bellissant E and Cavaillon JM:
Septic shock. Lancet. 365:63–78. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Greco M, Palumbo C, Sicuro F and Lobreglio
G: Soluble Fms-like tyrosine kinase-1 is a marker of endothelial
dysfunction during sepsis. J Clin Med Res. 10:700–706. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lundberg OH, Bergenzaun L, Rydén J,
Rosenqvist M, Melander O and Chew MS: Adrenomedullin and
endothelin-1 are associated with myocardial injury and death in
septic shock patients. Crit Care. 20:1782016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mai N, Prifti L, Rininger A, Bazarian H
and Halterman MW: Endotoxemia induces lung-brain coupling and
multi-organ injury following cerebral ischemia-reperfusion. Exp
Neurol. 297:82–91. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wan P, Tan X, Xiang Y, Tong H and Yu M:
PI3K/AKT and CD40L signaling regulate platelet activation and
endothelial cell damage in sepsis. Inflammation. 41:1815–1824.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang P, Hu Y, Yao D and Li Y: Omi/HtrA2
regulates a mitochondria-dependent apoptotic pathway in a murine
model of septic encephalopathy. Cell Physiol Biochem. 49:2163–2173.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamaguchi J, Nagase M, Yamamoto Y, Sakurai
A, Kubo A, Mitsuhashi H, Matsuoka M, Ihara S and Kinoshita K:
Increased oxidative stress and renal injury in patients with
sepsis. J Clin Biochem Nutr. 63:137–143. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dharap SB and Ekhande SV: An observational
study of incidence, risk factors and outcome of systemic
inflammatory response & organ dysfunction following major
trauma. Indian J Med Res. 146:346–353. 2017.PubMed/NCBI
|
|
9
|
Qiao Z, Wang W, Yin L, Luo P, Greven J,
Horst K and Hildebrand F: Using IL-6 concentrations in the first 24
h following trauma to predict immunological complications and
mortality in trauma patients: A meta-analysis. Eur J Trauma Emerg
Surg. 44:679–687. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Minamino T and Komuro I: Regeneration of
the endothelium as a novel therapeutic strategy for acute lung
injury. J Clin Invest. 116:2316–2319. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Winters BD, Eberlein M, Leung J, Needham
DM, Pronovost PJ and Sevransky JE: Long-term mortality and quality
of life in sepsis: A systematic review. Crit Care Med.
38:1276–1283. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsalik EL and Woods CW: Sepsis redefined:
The search for surrogate markers. Int J Antimicrob Agents. 34 Suppl
4:S16–S20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wood KA and Angus DC: Pharmacoeconomic
implications of new therapies in sepsis. Pharmacoeconomics.
22:895–906. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
O'Neill R, Morales J and Jule M: Early
goal-directed therapy (EGDT) for severe sepsis/septic shock: Which
components of treatment are more difficult to implement in a
community-based emergency department? J Emerg Med. 42:503–510.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kolgazi M, Şener G, Çetinel S, Gedik N and
Alican I: Resveratrol reduces renal and lung injury caused by
sepsis in rats. J Surg Res. 134:315–321. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sebai H, Sani M, Ghanem-Boughanmi N and
Aouani E: Prevention of lipopolysaccharide-induced mouse lethality
by resveratrol. Food Chem Toxicol. 48:1543–1549. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murakami M, Yoshihara K, Shimbara S,
Lambeau G, Singer A, Gelb MH, Sawada M, Inagaki N, Nagai H and Kudo
I: Arachidonate release and eicosanoid generation by group IIE
phospholipase A(2). Biochem Biophys Res Commun. 292:689–696. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou JH, Wei XM, Lan HH, Zhen N, Li JW and
Chen H: Protective effects of resveratrol on acute lung injury in
septic rats and its effect on HMGB1 and TLR4 mRNA expression. Chin
Pharmacol Clin. 31:138–139. 2015.
|
|
19
|
Palomera-Ávalos V, Griñán-Ferré C,
Izquierdo V, Camins A, Sanfeliu C, Canudas AM and Pallàs M:
Resveratrol modulates response against acute inflammatory stimuli
in aged mouse brain. Exp Gerontol. 102:3–11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim YA, Kim GY, Park KY and Choi YH:
Resveratrol inhibits nitric oxide and prostaglandin E2 production
by lipopolysaccharide-activated C6 microglia. J Med Food.
10:218–224. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lei M, Wang JG, Xiao DM, Fan M, Wang DP,
Xiong JY, Chen Y, Ding Y and Liu SL: Resveratrol inhibits
interleukin 1β-mediated inducible nitric oxide synthase expression
in articular chondrocytes by activating SIRT1 and thereby
suppressing nuclear factor-κB activity. Eur J Pharmacol. 674:73–79.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oh YC, Kang OH, Choi JG, Chae HS, Lee YS,
Brice OO, Jung HJ, Hong SH, Lee YM and Kwon DY: Anti-inflammatory
effect of resveratrol by inhibition of IL-8 production in
LPS-induced THP-1 cells. Am J Chin Med. 37:1203–1214. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ge L, Liu L, Liu H, Liu S, Xue H, Wang X,
Yuan L, Wang Z and Liu D: Resveratrol abrogates
lipopolysaccharide-induced depressive-like behavior,
neuroinflammatory response, and CREB/BDNF signaling in mice. Eur J
Pharmacol. 768:49–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma C, Wang Y, Dong L, Li M and Cai W:
Anti-inflammatory effect of resveratrol through the suppression of
NF-κB and JAK/STAT signaling pathways. Acta Biochim Biophys Sin
(Shanghai). 47:207–213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gualdoni GA, Kovarik JJ, Hofer J, Dose F,
Pignitter M, Doberer D, Steinberger P, Somoza V, Wolzt M and
Zlabinger GJ: Resveratrol enhances TNF-α production in human
monocytes upon bacterial stimulation. Biochim Biophys Acta.
1840:95–105. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bhattarai G, Poudel SB, Kook SH and Lee
JC: Resveratrol prevents alveolar bone loss in an experimental rat
model of periodontitis. Acta Biomater. 29:398–408. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tamaki N, Cristina Orihuela-Campos R,
Inagaki Y, Fukui M, Nagata T and Ito HO: Resveratrol improves
oxidative stress and prevents the progression of periodontitis via
the activation of the Sirt1/AMPK and the Nrf2/antioxidant defense
pathways in a rat periodontitis model. Free Radic Biol Med.
75:222–229. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bai T, Hu X, Zheng Y, Wang S, Kong J and
Cai L: Resveratrol protects against lipopolysaccharide-induced
cardiac dysfunction by enhancing SERCA2a activity through promoting
the phospholamban oligomerization. Am J Physiol Heart Circ Physiol.
311:H1051–H1062. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Imamura Y, Yoshikawa N, Murkami Y, Mitani
S, Matsumoto N, Matsumoto H, Yamada T, Yamakawa K, Nakagawa J,
Ogura H, et al: Effect of histone acetylation on
N-Methyl-D-Aspartate 2B receptor subunits and interleukin-1
receptors in association with nociception-related somatosensory
cortex dysfunction in a mouse model of sepsis. Shock. 45:660–667.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Y, Wang X, Zhang L and Zhang R:
Alleviation of acute lung injury in rats with sepsis by resveratrol
via the phosphatidylinositol 3-kinase/nuclear factor-erythroid 2
related factor 2/heme oxygenase-1 (PI3K/Nrf2/HO-1) pathway. Med Sci
Monit. 24:3604–3611. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hao E, Lang F, Chen Y, Zhang H, Cong X,
Shen X and Su G: Resveratrol alleviates endotoxin-induced
myocardial toxicity via the Nrf2 transcription factor. PLoS One.
8:e694522013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang N, Mao L, Yang L, Zou J, Liu K, Liu
M, Zhang H, Xiao X and Wang K: Resveratrol protects against early
polymicrobial sepsis-induced acute kidney injury through inhibiting
endoplasmic reticulum stress-activated NF-κB pathway. Oncotarget.
8:36449–36461. 2017.PubMed/NCBI
|
|
33
|
Li H: Negative regulation of Keap1-Nrf2
pathway by NF-κB pathway and its molecular mechanism. Tianjin
University. Publication no. Q257. 2009
|
|
34
|
Teboul JL and Duranteau J: Alteration of
microcirculation in sepsis: A reality but how to go further? Crit
Care Med. 40:1653–1654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lundy DJ and Trzeciak S: Microcirculatory
dysfunction in sepsis. Crit Care Nurs Clin North Am. 23:67–77.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Holthoff JH, Wang Z, Seely KA, Gokden N
and Mayeux PR: Resveratrol improves renal microcirculation,
protects the tubular epithelium, and prolongs survival in a mouse
model of sepsis-induced acute kidney injury. Kidney Int.
81:370–378. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pendurthi UR, Meng F, Mackman N and Rao
LV: Mechanism of resveratrol-mediated suppression of tissue factor
gene expression. Thromb Haemost. 87:155–162. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hamburger T, Broecker-Preuss M, Hartmann
M, Schade FU, de Groot H and Petrat F: Effects of glycine,
pyruvate, resveratrol, and nitrite on tissue injury and cytokine
response in endotoxemic rats. J Surg Res. 183:e7–e21. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang M, Jing LJ and Jing CH: Protective
effect of resveratrol on injured organs In endotoxic shock rats.
Chin Crit Care Med. 7:352–354. 1995.
|
|
40
|
Larrosa M, Azorín-Ortuño M, Yañez-Gascón
MJ, García-Conesa MT, Tomás-Barberán F and Espín JC: Lack of effect
of oral administration of resveratrol in LPS-induced systemic
inflammation. Eur J Nutr. 50:673–680. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Aydın S, Şahin TT, Bacanlı M, Taner G,
Başaran AA, Aydın M and Başaran N: Resveratrol protects
sepsis-induced oxidative DNA damage in liver and kidney of rats.
Balkan Med J. 33:594–601. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lou SC: Protective effect and mechanism of
resveratrol on cardiac function in septic shock rats. China Medical
University. Publication no. AAT 3411606. 2017
|
|
43
|
Wang X, Buechler NL, Yoza BK, McCall CE
and Vachharajani VT: Resveratrol attenuates microvascular
inflammation in sepsis via SIRT-1-Induced modulation of adhesion
molecules in ob/ob mice. Obesity (Silver Spring). 23:1209–1217.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang XJ: Protective effect of resveratrol
on myocardial injury in septic rats. Chin Pharmacol Clin Med.
31:51–54. 2015.
|
|
45
|
Gan YZ: Protective effects of resveratrol
on acute kidney injury in septic rats and its effect on the
expression of NF-κB p65. Southern Medical University. Publication
no. R631.2 R285.5. 2016
|
|
46
|
Huang J: Effects of resveratrol on the
expression of inflammatory factors and myocardial damage in sepsis.
Guangzhou University of Traditional Chinese Medicine. 2015.
|
|
47
|
Wang Y: The effect of resveratrol on
hemorheology of lipopolysaccharide challenged rats. Hebei Northern
College. Publication no. R572.2. 2015
|
|
48
|
Gan Y, Tao S, Cao D, Xie H and Zeng Q:
Protection of resveratrol on acute kidney injury in septic rats.
Hum Exp Toxicol. 36:1015–1022. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li M: Protective effect and mechanism of
resveratrol on acute kidney injury in septic rats. Central South
University. Publication no. R459.7. 2013
|
|
50
|
Chen L, Yang S, Zumbrun EE, Guan H,
Nagarkatti PS and Nagarkatti M: Resveratrol attenuates
lipopolysaccharide-induced acute kidney injury by suppressing
inflammation driven by macrophages. Mol Nutr Food Res. 59:853–864.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bah I, Kumbhare A, Nguyen L, McCall CE and
El Gazzar M: IL-10 induces an immune repressor pathway in sepsis by
promoting S100A9 nuclear localization and MDSC development. Cell
Immunol. 332:32–38. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Park HJ, Lee SJ, Cho J, Gharbi A, Han HD,
Kang TH, Kim Y, Lee Y, Park WS, Jung ID, et al: Tamarixetin
exhibits anti-inflammatory activity and prevents bacterial sepsis
by increasing IL-10 production. J Nat Prod. 81:1435–1443. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yu YX, Fan J and Zhang M: Protective
effects of resveratrol on acute lung injury in septic rats and its
effect on the expression of inflammatory protein-2, IL-10 and IL-18
in macrophages. Chin J Biol Prod. 25:1003–1006. 2012.
|
|
54
|
Cerqueira AM, Khaper N, Lees SJ and
Ulanova M: The antioxidant resveratrol down-regulates inflammation
in an in-vitro model of Pseudomonas aeruginosa infection of
lung epithelial cells. Can J Physiol Pharmacol. 91:248–255. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Silswal N, Reddy NS, Qureshi AA and
Qureshi N: Resveratrol downregulates biomarkers of sepsis via
inhibition of proteasome's proteases. Shock. 50:579–588. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li WG and Chen XP: Effect of resveratrol
on TNF-α promoter region of THP-1 cells induced by bacterial
lipopolysaccharide. Chin J Gen Surg. 25:686–692. 2016.
|
|
57
|
Chen GD, Yu WD and Chen XP: sirT1
activator represses the transcription of TNF-α in THP-1 cells of a
sepsis model via deacetylation of H4K16. Mol Med Rep. 14:5544–5550.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Sebai H, Ristorcelli E, Sbarra V,
Hovsepian S, Fayet G, Aouani E and Lombardo D: Protective effect of
resveratrol against LPS-induced extracellular lipoperoxidation in
AR42J cells partly via a Myd88-dependent signaling pathway. Arch
Biochem Biophys. 495:56–61. 2010. View Article : Google Scholar : PubMed/NCBI
|
